🇺🇸 FDA

Intelligence Platform

Pipeline programs

Browse 12,558 clinical pipeline programs from ClinicalTrials.gov, linked to pharma companies. Phase, modality, and trial IDs for BD teams.

12,558 programs 407 companies
project

Active CTC Assessment

UNITED THERAPEUTICS Corp

Phase 3 · other · terminated

1 trials project

Active Surveillance

Black Diamond Therapeutics

Phase 3 · other · active

1 trials project

Active referral

BRIGHT MINDS BIOSCIENCES INC.

Phase 3 · other · active

1 trials project

Actovegin

TAKEDA PHARMACEUTICAL CO LTD

Phase 3 · small_molecule · completed

1 trials project

Actovegin

TAKEDA PHARMACEUTICAL CO LTD

Phase 3 · small_molecule · completed

1 trials project

Acupuncture

Summit Therapeutics

Phase 3 · other · active

1 trials project

Acyclovir

BRIGHT MINDS BIOSCIENCES INC.

Phase 3 · small_molecule · completed

1 trials project

Adderall-XR

BRIGHT MINDS BIOSCIENCES INC.

Phase 3 · small_molecule · completed

1 trials project

Adjuvant Immunomodulatory (IM) Therapy

Ultragenyx Pharmaceutical

Phase 3 · small_molecule · active

1 trials project

Adjuvant chemotherapy

China SXT Pharmaceuticals

Phase 3 · small_molecule · active

1 trials project

Adjuvant immunotherapy

China SXT Pharmaceuticals

Phase 3 · small_molecule · active

1 trials project

Adsorbed COVID-19 (inactivated) Vaccine

SINOVAC BIOTECH LTD

Phase 3 · mab · completed

1 trials project

Adynovate

TAKEDA PHARMACEUTICAL CO LTD

Phase 3 · mab · completed

1 trials project

Aerobic Exercise

First Tracks Biotherapeutics

Phase 3 · other · active

1 trials project

Aflibercept

REGENERON PHARMACEUTICALS, INC.

Phase 3 · small_molecule · completed

3 trials project

Aflibercept

REGENERON PHARMACEUTICALS, INC.

Phase 3 · small_molecule · completed

1 trials project

Aflibercept (EYLEA, BAY86-5321)

REGENERON PHARMACEUTICALS, INC.

Phase 3 · small_molecule · completed

1 trials project

Aflibercept (Eylea, BAY 86-5321)

REGENERON PHARMACEUTICALS, INC.

Phase 3 · small_molecule · completed

1 trials project

Aflibercept (Eylea, VEGF Trap-Eye, BAY86-5321)

REGENERON PHARMACEUTICALS, INC.

Phase 3 · mab · completed

1 trials project

Aflibercept (Eylea, VEGF Trap-Eye, BAY86-5321)

REGENERON PHARMACEUTICALS, INC.

Phase 3 · mab · completed

1 trials project

Aflibercept (ziv-aflibercept, AVE0005, VEGF trap, ZALTRAP®)

REGENERON PHARMACEUTICALS, INC.

Phase 3 · small_molecule · terminated

1 trials project

Aflibercept (ziv-aflibercept, AVE0005, VEGF trap, ZALTRAP®)

REGENERON PHARMACEUTICALS, INC.

Phase 3 · small_molecule · completed

1 trials project

Aflibercept 8 mg

REGENERON PHARMACEUTICALS, INC.

Phase 3 · small_molecule · active

1 trials project

Aflibercept AVE0005

REGENERON PHARMACEUTICALS, INC.

Phase 3 · small_molecule · terminated

2 trials